2,354 material Form 8-K filings that 2,004 companies we cover made with the SEC in November 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). 1,081 of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Algorhythm Holdings' CEO and Chairman Andrew Thompson resigned effective immediately, with the board stating no disagreement over operations, policies or practices. Director Gregory D. Smith was appointed to both roles on November 2, 2026, under a CEO agreement with a base salary of $375,000 rising to $480,000 on performance conditions.
Andrew Thompson resigned as CEO and Chairman, accepted by the board on October 30, 2026.
Gregory D. Smith, age 67 and a board member since September 2026, became CEO and Chairman on November 2, 2026.
Smith's agreement provides a 2,119,542-share restricted stock award, with 1,059,771 shares vesting immediately and 1,059,771 vesting on the first anniversary of the effective date.
Severance equals two times base salary plus maximum annual bonus; the filing reports 40,848,979 common shares outstanding as of November 4, 2026.
Datavault AI's board removed Nathaniel Bradley as Chief Executive Officer and President and terminated his employment, effective immediately, on November 1, 2026. The action was approved by all directors except Mr. Bradley, who voted against it, and he continues to serve as a board member. The filing does not name a successor or an interim leader, leaving the company's top executive role open as of the filing date.
Removal effective November 1, 2026, with employment terminated immediately
Board action approved by all directors other than Mr. Bradley, who voted against it
Mr. Bradley remains a board member until the next annual meeting or earlier resignation or removal
Change Agents Corporation appointed Chief Strategy Officer Luisa Ingargiola as principal executive officer on November 4, 2026, until it names a new Chief Executive Officer, with no added compensation. The company also issued a $250,000 promissory note to Harllon Holdings LLC with a $75,000 original issue discount, requiring repayment of $325,000 on January 1, 2027, and agreed to issue 150,000 shares to consultants for services.
Luisa Ingargiola, Chief Strategy Officer since June 3, 2026, was appointed principal executive officer on November 4, 2026, and will receive no additional compensation for the role.
Promissory note issued November 4, 2026 to Harllon Holdings LLC: $250,000 principal, $75,000 original issue discount, $325,000 due January 1, 2027.
The note may be prepaid on December 1, 2026 for $312,000.
150,000 shares of common stock agreed to be issued to consultants for services, under the Section 4(a)(2) registration exemption.
Lulu's Fashion Lounge Holdings said its President and Chief Information Officer, Mark Vos, will leave the company when his employment ends on December 31, 2026, at the end of the current term under his employment agreement. The company and Mr. Vos are still discussing possible post-employment consulting and transition terms, and the filing gives no financial results or replacement details.
Mark Vos's employment as President and Chief Information Officer ends December 31, 2026
Agreement to end employment was reached October 30, 2026, and he continues in his role until then
Post-employment consulting services and transition terms remain under discussion
Krispy Kreme's board approved an amendment to CEO Joshua Charlesworth's employment agreement on October 30, 2026. The change raises his annual cash target bonus from 100% to 150% of base salary, effective November 1, 2026, and increases his annual restricted stock unit grant from $1,000,000 to $2,500,000, starting with the 2027 grant. The filing does not state a financial reason for the change, but it raises the potential pay of the company's top executive.
Target annual cash bonus rises from 100% to 150% of base salary, effective November 1, 2026.
Annual restricted stock unit grant increases from $1,000,000 to $2,500,000, beginning with the 2027 annual grant.
Changes were approved by the Board of Directors on October 30, 2026 and disclosed in a filing dated November 5, 2026.
Micron Technology said director Linnie M. Haynesworth will retire from its board and will not stand for re-election. She will serve until the annual shareholders meeting expected on January 14, 2027, and the board will have eight directors after her departure. The filing describes the change as a planned board retirement and does not describe any change in company operations or financial results.
Haynesworth notified the Governance and Sustainability Committee on November 2, 2026, and the company announced the retirement on November 5, 2026.
She will remain a director through the end of her term at the annual shareholders meeting expected on January 14, 2027.
She chaired the Security Committee from 2024 to 2026 and currently serves on the Audit and Compensation Committees.
The board has nominated eight current directors for re-election, including Sanjay Mehrotra and Lynn A. Dugle.
Goodyear's board elected David E. Phillips as Executive Vice President, Chief Legal Officer and Head of Enterprise Transformation, effective November 1, 2026. The filing sets his base salary at $850,000 and his annual incentive target at $850,000, and says a restricted stock unit grant with a grant date fair value of $1,250,000 is expected in February 2027.
Effective date of appointment: November 1, 2026
Base salary: $850,000; annual incentive target: $850,000
Expected RSU grant with grant date fair value of $1,250,000 in February 2027 under the 2022 Performance Plan
AIAI Holdings Corp disclosed that directors Donald M. Remy and Jeanne L. Phillips each notified the Board on October 30, 2026 of their intention to resign, effective that same day. The company states that neither resignation resulted from any dispute or disagreement with the company or the Board about its operations, policies or practices. The filing does not name replacements or other financial effects.
Donald M. Remy resigned as a director, effective October 30, 2026
Jeanne L. Phillips resigned as a director, effective October 30, 2026
Company says neither resignation involved a disagreement on operations, policies or practices
Filing was signed by CEO Todd Furniss on November 5, 2026
On November 4, 2026, Stewart Information Services increased its Board from ten to eleven members and appointed Michael Brown as a director, effective immediately. Brown was also named to the Audit Committee, and the Board determined he is independent and an audit committee financial expert. The change adds a new director but does not alter executive leadership or financial results.
Board size increased from ten to eleven; Michael Brown appointed effective immediately on November 4, 2026
Brown joins the Audit Committee; his term runs to the 2027 Annual Meeting of Stockholders
Brown is COO and a director of MC Bancshares, Inc. and previously served as President of Regional Banking at First Horizon Corporation
Brown received a prorated equity award and a prorated cash retainer, based on the November 4, 2026 closing price
PNC's board appointed Alexander E. C. Overstrom, currently executive vice president and head of Retail Banking, as chief financial officer effective March 1, 2027. Robert Q. Reilly, the current CFO, will become executive vice chairman on the same date, serving as a senior executive advisor to Chairman and CEO William S. Demchak. The filing does not report financial results, so it contains no direct measure of business performance.
Alexander E. C. Overstrom, 42, joined PNC in 2014 and has led Retail Banking since July 2022.
Robert Q. Reilly has been CFO since 2013 and remains in the role until March 1, 2027.
Permanent successor for PNC Retail Banking will be named in the near future.
Blaize Holdings appointed Martin Costas as Chief Operations Officer and Chief Financial Officer, effective November 2, 2026, replacing CFO Harminder Sehmi, who is retiring and will assist with the transition through November 30, 2026. The filing discloses Costas's pay, including a $425,000 base salary and option grants, and the bonus he can earn tied to raising $10 million and $50 million in net financing proceeds, which links his incentive to capital raising.
Martin Costas appointed COO and CFO effective November 2, 2026; he reports to CEO Dinakar Munagala.
Harminder Sehmi retiring as CFO; transition expected to be completed by November 30, 2026.
Costas base salary is $425,000, with a target bonus of 50% of base salary tied to Qualified Financings: $10 million by December 31, 2026, and $50 million between January 1 and June 30, 2027.
Costas receives options on 4,787,837 time-vesting shares and 2,393,918 performance-vesting shares, the latter vesting if market capitalization is at least $500 million for 60 consecutive days.
Valion Bio, Inc. disclosed that Lisa Wolf, its President, Chief Operating Officer and Chief Financial Officer, has voluntarily resigned from all three roles, with the resignation effective December 11, 2026. The filing does not state a reason or name a successor, so shareholders will need to watch for a replacement announcement.
Lisa Wolf notified the Special Committee of the Board on October 31, 2026.
Her resignation covers the positions of President, Chief Operating Officer and Chief Financial Officer.
The resignation takes effect December 11, 2026, and had not yet taken effect as of the filing date.
Steven L. Bernstein retired as Chief Financial Officer, Treasurer and Secretary of Frequency Electronics, Inc. effective November 1, 2026, and will provide transition services under a consulting agreement with an initial term ending October 31, 2027. The filing sets out his consulting fee, post-retirement benefits and the conditions under which those benefits apply, which shareholders may want to note when assessing the company's finance leadership transition.
Retirement effective November 1, 2026; agreement signed October 31, 2026, effective November 1, 2026
Annual consulting fee of $282,505, paid monthly, plus pre-approved expense reimbursement
Initial consulting term ends October 31, 2027; equity awards continue to vest during the term
Annual lifetime benefit of $38,000 under his 2015 deferred compensation agreement if the term is completed or ended without Cause, subject to a release of claims
TransUnion's board appointed David Gilbert, currently Senior Vice President and CFO for International, as interim Chief Financial Officer effective January 1, 2027. The change follows CFO Todd Cello's previously announced resignation effective December 31, 2026, after which Cello will serve as a full-time advisor through March 1, 2027. The company says it continues to search for a permanent CFO.
David Gilbert, who joined TransUnion in 1991, becomes interim CFO effective January 1, 2027.
Gilbert receives a $15,000 monthly stipend for his interim service.
Separate retention awards include $150,000 in cash, paid 50% in June 2027 and 50% in December 2027, and restricted stock units with a $150,000 grant date value that vest on the first anniversary of the grant.
Todd Cello resigned as CFO on September 19, 2026, effective December 31, 2026.
Biodesix said the employment of Chief Commercial Officer Kieran O'Kane ends effective November 2, 2026. He is eligible for separation benefits under his existing Executive Severance and Change in Control Agreement, based on a qualifying termination.
Kieran O'Kane, Chief Commercial Officer, departs effective November 2, 2026, the agreed Separation Date.
Separation benefits are available under his existing Executive Severance and Change in Control Agreement, as described in the 2026 proxy statement filed April 9, 2026.
The filing does not state the dollar value of the separation benefits or name a replacement.
Winnebago Industries disclosed that Stacy L. Bogart, Senior Vice President, Chief Legal Officer and Corporate Secretary, has decided to retire effective December 31, 2026. The company plans to name a successor on or before that date, so shareholders will learn who replaces her in the coming weeks.
Stacy L. Bogart notified the company of her retirement decision on October 31, 2026
Retirement is effective December 31, 2026
Company plans to announce a successor on or before December 31, 2026
Bogart also holds the Corporate Secretary and Corporate Responsibility roles
Longeveron Inc. said director Ursula Ungaro resigned immediately on November 1, 2026, from its Board of Directors and from its Audit, Compensation, Nominating and Corporate Governance, and Special Committees. She cited personal health issues and said the decision was not due to any disagreement with the company on operations, policies or practices.
Resignation notice given November 1, 2026, effective immediately
Ms. Ungaro left the Board and four board committees: Audit, Compensation, Nominating and Corporate Governance, and Special
Stated reason is personal health issues; no disagreement with the company is reported
The filing does not name a replacement director or describe any succession plan
BridgeBio Oncology Therapeutics said its Chief Medical and Development Officer, Yong Ben, gave notice of his resignation on October 30, 2026, effective January 8, 2027. The filing states the departure was not due to any disagreement with the company's operations, policies or practices, and it does not name a successor.
Yong Ben gave notice of resignation as Chief Medical and Development Officer on October 30, 2026.
Resignation takes effect January 8, 2027.
The company states the resignation was not due to any disagreement over operations, policies or practices.
Devin G. Nunes notified the board of Renatus Tactical Acquisition Corp I on October 31, 2026, that he is resigning as a director and as Chairman, effective the same day. The company said the resignation was not due to any dispute or disagreement over its operations, policies or practices. The board now has three independent directors, one non-independent director and one vacant seat, and the company is searching for an independent director to fill it.
Devin G. Nunes resigned as director and Chairman of the Board, effective October 31, 2026
The company states the resignation was not due to any dispute or disagreement with the company or board
Board now has three independent directors, one non-independent director and one vacant seat
The company is currently searching for an independent director to join the board
Graham Holdings Company (NYSE: GHC) elected Robert J. Mylod Jr. to its Board of Directors on November 5, 2026. The Board has determined he is an independent director under NYSE listing standards, and he will receive the same non-employee director compensation as the company's other non-employee directors.
Election date: November 5, 2026; the Board has not yet decided whether he will serve on any committee.
Mylod is Managing Partner of Annox Capital Management, a private investment firm he founded in 2013.
He was formerly Chief Financial Officer and Vice Chairman of Booking Holdings from 2000 to 2009.
Director pay is an annual cash retainer, with an option to take part in fully vested Class B shares.
Digital Turbine appointed Daniel Lentz as Chief Financial Officer effective November 2, 2026, replacing Joshua Kinsell, who was interim CFO and remains Chief Accounting Officer. Lentz's pay package includes a $450,000 base salary, a $100,000 signing bonus and performance- and time-based equity awards, which tie part of his compensation to future Adjusted EBITDA and relative shareholder return.
Daniel Lentz, 48, previously served as CFO of Commerce.com, Inc. from July 2023 until joining Digital Turbine.
Lentz's compensation includes a $450,000 annual base salary, a $100,000 signing bonus and a target annual bonus of up to 100% of base salary.
Lentz received long-term awards of $1,050,000 in performance stock units and $1,050,000 in time-based restricted stock units, granted November 30, 2026.
Joshua Kinsell stepped down as interim CFO effective November 2, 2026, and continues as Chief Accounting Officer.
GE HealthCare said Taha Kass-Hout notified the company on November 4, 2026 that he will resign as Chief Science and Technology Officer. His last day will be December 31, 2026. The filing gives no successor name or reason for the departure.
Taha Kass-Hout will resign as Chief Science and Technology Officer.
He notified GE HealthCare on November 4, 2026.
His last day at the company will be December 31, 2026.
The RealReal increased its board from seven to eight directors and appointed Sharmistha Dubey, former CEO of Match Group, as a Class II director effective November 3, 2026. The filing reports no financial results, guidance or transactions, so the change is a governance addition rather than a change in company performance.
Board expanded from seven to eight directors; Dubey's term runs to the 2027 annual meeting.
Dubey was CEO of Match Group from March 2020 to May 2022 and served on Match's board from March 2019 to June 2026.
Non-employee director pay includes a $35,000 annual cash retainer and a $165,000 annual restricted stock unit award.
Dubey also chairs the board of Fortive Corporation and serves as a director of Naspers and Prosus.
Gibraltar Industries said Chief Financial Officer Joseph Lovechio will resign effective November 20, 2026, to pursue another opportunity, and that the filing states his departure was not due to any disagreement on operations, financial reporting, policies or practices. Treasurer Jeffrey Watorek will serve as Interim Chief Financial Officer while the company searches for a permanent successor. The change is a senior finance leadership transition, but the filing includes no financial results or guidance.
Joseph A. Lovechio resigns as Vice President and CFO, effective November 20, 2026
Jeffrey J. Watorek, Vice President and Treasurer, appointed Interim CFO, with $5,750 additional biweekly cash compensation
Lori Rizzo, Vice President and Corporate Controller, appointed principal accounting officer effective November 20, 2026
Company has commenced a search for its next Chief Financial Officer
Middleby said CEO Tim FitzGerald will step down as CEO and from the board effective March 31, 2027, and that Chief Commercial Officer Steve Spittle will become CEO on April 1, 2027. Spittle was named President effective November 5, 2026, and will join the board when he becomes CEO. The company said the succession follows its 2026 portfolio transformation and that it is also reporting third quarter 2026 results on the same day.
Timothy J. FitzGerald leaves the CEO role and the board effective March 31, 2027, and remains eligible for severance and pro-rated accelerated vesting of restricted stock units.
Steven P. Spittle became President effective November 5, 2026, and becomes CEO and a board member effective April 1, 2027.
Spittle's employment agreement, dated November 4, 2026, sets an annual base salary of $850,000 and eligibility for an annual bonus.
Tripadvisor said CEO Matt Goldberg will leave his roles as president, CEO and board member effective February 16, 2027, under a separation agreement signed November 4, 2026. CFO Michael Noonan will resign effective December 31, 2026 to pursue another opportunity, and Chief Strategy and Operations Officer Kristen Dalton will serve as interim CFO starting January 1, 2027. The filing says the departures are not the result of any disagreement with the company, and the board is working with an executive search firm to find successor leadership.
Goldberg's separation package includes $675,000 in base salary payments over 18 months and a $675,000 bonus-based payment, subject to a release and restrictive covenants.
Goldberg remains CEO through February 16, 2027, and Noonan remains CFO through December 31, 2026.
Kristen Dalton, Chief Strategy and Operations Officer since November 2025, becomes interim CFO on January 1, 2027.
Chair Jeremy Philips said the board is working with an executive search firm to identify candidates.
1stDibs reported third quarter 2026 net revenue of $23.1 million, up 5% year over year, and a net loss of $1.2 million, narrower than the $3.5 million loss a year earlier. The same day, the company said Chief Product and Marketing Officer Bradford Shellhammer will succeed David Rosenblatt as CEO on January 1, 2027, with Rosenblatt moving to Executive Chairperson.
Q3 2026 net revenue was $23.1 million, up 5% year over year; gross margin was 73.2%, compared with 74.3% in Q3 2025.
Q3 2026 Adjusted EBITDA was $1.0 million (4.5% margin), compared with $(0.2) million a year earlier; the company called it its fourth consecutive quarter of positive Adjusted EBITDA.
Q4 2026 guidance: net revenue $22.2 million to $23.4 million; Adjusted EBITDA margin 1% to 4%.
Shellhammer succeeds Rosenblatt as CEO on January 1, 2027; the board authorized a $5.0 million share repurchase on November 3, 2026.
Latigo Biotherapeutics reported a third-quarter 2026 net loss of $20.9 million, down from $24.8 million a year earlier, and cash of $401.2 million that the company expects will fund operations into 2029. The company also said Todd Smith became president and CEO effective November 3, 2026, replacing Nima Farzan, who also resigned from the board.
Q3 2026 net loss was $20.9 million, versus $24.8 million in Q3 2025; R&D expenses fell to $17.5 million from $22.1 million, while G&A rose to $5.4 million from $2.6 million.
Cash and cash equivalents were $401.2 million as of September 30, 2026, expected to fund current operating plans into 2029.
Todd Smith became CEO effective November 3, 2026, with a $775,000 base salary, a 70% target cash incentive, and an option award with a $20 million grant-date fair value.
Nima Farzan will remain an employee through January 1, 2027, receive his 2026 bonus at 100% of target, and then serve as a consultant through December 31, 2027.
Brady Corporation entered into a Share Exchange Agreement on November 4, 2026, in which William H. Brady III transferred all 1,769,314 of his Class B Common Stock shares to the company in exchange for an equal number of newly issued Class A Common Stock shares. As a result of the transaction, Elizabeth P. Bruno now holds 100% of the Class B Common Stock, representing all of the company's voting power and resulting in a change in control. Dr. Bruno also stepped down from independent board committees, and the company qualified as a controlled company under NYSE rules.
On November 4, 2026, William H. Brady III exchanged 1,769,314 shares of Class B Common Stock for 1,769,314 newly issued shares of Class A Common Stock.
Elizabeth P. Bruno acquired 100% control of the company's Class B Common Stock voting power, resulting in a change in control.
William H. Brady III agreed to a 24-month lock-up period on the newly issued Class A Common Stock.
Dr. Bruno stepped down from the Management Development and Compensation Committee and the Corporate Governance Committee.
Microsoft said director Emma N. Walmsley, on the board since 2019, told the company on November 4, 2026 that she will not stand for re-election at the 2026 annual shareholder meeting. She will remain a director until that meeting, and the filing says her decision was not due to any disagreement with management.
Emma N. Walmsley informed Microsoft on November 4, 2026 of her decision not to seek re-election.
Walmsley has served on the board since 2019 and will continue as a director until the 2026 annual meeting.
The filing states no disagreement with management on operations, policies, or practices led to the decision.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.